首页 >
法规速递
-
Page: List of medicines under additional monitoring-2025/9/24
2025-09-25查看详情 > -
Document: Policy 46: European Medicines Agency policy on video surveillance-2025/11/3
2025-11-04查看详情 > -
关于将甲磺酸瑞索利塞（CYH33）纳入“儿童抗肿瘤药物研发鼓励试点计划（星光计划）”试点项目的公示-2025/12/3
2025-12-04查看详情 > -
Page: PRAC recommendations on safety signals-2026/1/6
2026-01-07查看详情 > -
Document: Article 57 product data-2026/2/10
2026-02-11查看详情 > -
Document: 2025 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission-2026/3/19
2026-03-20查看详情 > -
Page: Podcast: Inside EMA-2026/4/23
2026-04-24查看详情 > -
Document: Timetable: Safety referral (Article 107i, urgent Union procedure)-2026/6/4
2026-06-05查看详情 > -
关于暂行延长药品注册申请补充资料时限的公告（2022年第86号）-2022/10/14
2022-11-14查看详情 > -
Regulatory and procedural guideline: European Medicines Agency procedural advice on recommendations on unforeseen variations according to Article 5 of Commission Regulation (EC) No 1234/2008-2023/02/27
2023-02-27查看详情 >
